NEW YORK, Dec. 5, 2013 /PRNewswire/ -- Pomerantz Grossman Hufford Dahlstrom & Gross LLP is investigating claims on behalf of investors of Ambit Biosciences Corporation ("Ambit" or the "Company")(NASDAQ: AMBI). Such investors are advised to contact Robert S. Willoughby at......
More...







